Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion.

Biological psychiatry·2026

Same author

Targeting mGlyR with nanobodies for depression.

Nature communications·2026

Same author

Chronic constriction of the sciatic nerve does not induce mood-related comorbidities in female mice.

Brain, behavior, and immunity·2026

Same author

GPR88 localization to primary cilia in neurons is cell-type specific.

Life science alliance·2025

Same author

Incubation of social deficit during morphine abstinence in male mice using a novel unbiased and automatized method.

Frontiers in behavioral neuroscience·2025

Same author

The GPR88 Agonist RTI-122 Reduces Alcohol-Related Motivation and Consumption.

Addiction biology·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

Reward processing by the opioid system in the brain.

Julie Le Merrer¹, Jérôme A J Becker, Katia Befort

¹Institut de Génétique et de Biologie Moléculaire et Cellulaire, Département Neurobiologie et Génétique, Illkirch, France.

Physiological Reviews

|October 1, 2009

Summary

The brain's opioid system, involving mu, delta, and kappa receptors, is crucial for reward and addiction. Understanding how opioid system modifications contribute to drug craving and relapse is key for developing new addiction therapies.

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

Related Experiment Videos

Last Updated: Jun 20, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

Area of Science:

Neuroscience
Addiction Research
Molecular Biology

Background:

The endogenous opioid system, comprising mu, delta, and kappa receptors activated by specific peptides, plays a vital role in processing natural rewards and responses to drugs of abuse.
Addiction development involves modifications to both endogenous opioids and their receptors, yet the precise mechanisms linking aberrant opioid system activity to drug craving and relapse are not fully understood.

Purpose of the Study:

To review current knowledge on brain regions controlling hedonic responses via the endogenous opioid system.
To summarize how the opioid system is altered by drug abuse in rodent models.
To highlight areas for future research in understanding the opioid system's role in addiction.

Main Methods:

Review of anatomical data on the opioid system.
Analysis of intracerebral pharmacological manipulations affecting reinforced behaviors.
Examination of gene knockout studies on reinforced behaviors and drug dependence.
Assessment of chronic drug exposure effects on opioid system gene expression.

Main Results:

The review consolidates information on the opioid system's anatomy and its functional roles in reward and addiction.
Pharmacological and genetic manipulations reveal the opioid system's control over reinforced behaviors and drug dependence.
Chronic drug exposure significantly alters the expression of opioid system genes.

Conclusions:

The endogenous opioid system is a critical target for understanding and treating addiction.
Further research is needed to identify specific molecular players and neural circuits involved in opioid-mediated addiction.
Findings have implications for developing novel therapeutic strategies for addiction disorders.